Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Journal of Pharmaceutical Sciences
|
July 1, 1972
Oral and parenteral formulations of marijuana constituents
H Rosenkrantz, G R Thompson, M C Braude
Toxicology and Applied Pharmacology
|
April 1, 1974
Inhalation, parenteral and oral LD50 values of delta 9-tetrahydrocannabinol in Fischer rats
H Rosenkrantz, I A Heyman, M C Braude
Life Sciences
|
September 1, 1977
Chronic effects of acetylmethadol and methadone in rhesus monkeys
D A Downs, D J Thomas, M C Braude
Pharmacology
|
January 1, 1974
Observations on the reproductive activity of chimpanzees following long-term exposure to marihuana
D M Grilly, D P Ferraro, M C Braude
Life Sciences
|
February 1, 1974
Delta9-tetrahydrocannabinol: subcortical spike bursts and motor manifestations in a Fischer rat treated orally for 109 days
S W Stadnicki, U Schaeppi, H Rosenkrantz, et al.
Toxicology and Applied Pharmacology
|
December 1, 1975
Chronic marihuana inhalation toxicity in rats
R W Fleischman, D W Hayden, M C Braude, et al.
Toxicology and Applied Pharmacology
|
July 1, 1973
Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys
G R Thompson, H Rosenkrantz, U H Schaeppi, et al.
Teratology
|
August 1, 1975
Teratologic evaluation of delta9-tetrahydrocannabinol in mice, including a review of the literature
R W Fleischman, D W Hayden, H Rosenkrantz, et al.
Toxicology and Applied Pharmacology
|
May 1, 1975
Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months
U L Luthra, H Rosenkrantz, I A Heyman, et al.
Toxicology
|
January 1, 1975
Effects of delta-9-tetrahydrocannabinol administered subcutaneously to rabbits for 28 days
G R Thompson, H Rosenkrantz, R W Fleischman, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Journal of Pharmaceutical Sciences
|
July 1, 1972
Oral and parenteral formulations of marijuana constituents
H Rosenkrantz, G R Thompson, M C Braude
Toxicology and Applied Pharmacology
|
April 1, 1974
Inhalation, parenteral and oral LD50 values of delta 9-tetrahydrocannabinol in Fischer rats
H Rosenkrantz, I A Heyman, M C Braude
Life Sciences
|
September 1, 1977
Chronic effects of acetylmethadol and methadone in rhesus monkeys
D A Downs, D J Thomas, M C Braude
Pharmacology
|
January 1, 1974
Observations on the reproductive activity of chimpanzees following long-term exposure to marihuana
D M Grilly, D P Ferraro, M C Braude
Life Sciences
|
February 1, 1974
Delta9-tetrahydrocannabinol: subcortical spike bursts and motor manifestations in a Fischer rat treated orally for 109 days
S W Stadnicki, U Schaeppi, H Rosenkrantz, et al.
Toxicology and Applied Pharmacology
|
December 1, 1975
Chronic marihuana inhalation toxicity in rats
R W Fleischman, D W Hayden, M C Braude, et al.
Toxicology and Applied Pharmacology
|
July 1, 1973
Comparison of acute oral toxicity of cannabinoids in rats, dogs and monkeys
G R Thompson, H Rosenkrantz, U H Schaeppi, et al.
Teratology
|
August 1, 1975
Teratologic evaluation of delta9-tetrahydrocannabinol in mice, including a review of the literature
R W Fleischman, D W Hayden, H Rosenkrantz, et al.
Toxicology and Applied Pharmacology
|
May 1, 1975
Differential neurochemistry and temporal pattern in rats treated orally with delta9-tetrahydrocannabinol for periods up to six months
U L Luthra, H Rosenkrantz, I A Heyman, et al.
Toxicology
|
January 1, 1975
Effects of delta-9-tetrahydrocannabinol administered subcutaneously to rabbits for 28 days
G R Thompson, H Rosenkrantz, R W Fleischman, et al.
Page
of 4